Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ADALIMUMAB-ATTO Cause Migraine? 5 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Migraine have been filed in association with ADALIMUMAB-ATTO. This represents 0.4% of all adverse event reports for ADALIMUMAB-ATTO.

5
Reports of Migraine with ADALIMUMAB-ATTO
0.4%
of all ADALIMUMAB-ATTO reports
2
Deaths
3
Hospitalizations

How Dangerous Is Migraine From ADALIMUMAB-ATTO?

Of the 5 reports, 2 (40.0%) resulted in death, 3 (60.0%) required hospitalization, and 2 (40.0%) were considered life-threatening.

Is Migraine Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ADALIMUMAB-ATTO. However, 5 reports have been filed with the FAERS database.

What Other Side Effects Does ADALIMUMAB-ATTO Cause?

Device difficult to use (328) Product storage error (279) Drug dose omission by device (219) Circumstance or information capable of leading to medication error (194) Accidental exposure to product (123) Injection site pain (100) Intercepted product administration error (75) Wrong technique in product usage process (69) Drug ineffective (48) Off label use (47)

What Other Drugs Cause Migraine?

ERENUMAB-AOOE (4,290) ADALIMUMAB (4,238) GALCANEZUMAB-GNLM (2,612) METHOTREXATE (2,532) ETANERCEPT (2,320) PREDNISONE (2,203) APREMILAST (2,154) INFLIXIMAB (2,137) RITUXIMAB (1,894) TOFACITINIB (1,878)

Which ADALIMUMAB-ATTO Alternatives Have Lower Migraine Risk?

ADALIMUMAB-ATTO vs ADALIMUMAB-BWWD ADALIMUMAB-ATTO vs ADALIMUMAB-FKJP ADALIMUMAB-ATTO vs ADALIMUMAB-RYVK ADALIMUMAB-ATTO vs ADALIMUMAB\ISOPROPYL ALCOHOL ADALIMUMAB-ATTO vs ADAPALENE

Related Pages

ADALIMUMAB-ATTO Full Profile All Migraine Reports All Drugs Causing Migraine ADALIMUMAB-ATTO Demographics